PUBLIC COMPANY
savePadagis LLC
updated 2mo ago
community read0 votes
pipeline
10
marketed
10
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(10)
pipeline depth10 products
10Marketed
Marketed
(bacitracin + hydrocortisone acetate + neomycin sulfate + polymyxin B)
Anterior Uveitis
Marketed(chlorpheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride)
Nasopharyngitis (Common Cold)
MarketedAMMONIUM LACTATE
Ichthyosis Vulgaris
MarketedClindesse
Bacterial Vaginosis
Marketedbacitracin
Bacterial Conjunctivitis
Marketedbutoconazole nitrate
Vulvovaginal Candidiasis
Marketedflavoxate hydrochloride
Chronic Bacterial Prostatitis
Marketedmethylphenidate ER
Attention Deficit Hyperactivity Disorder (ADHD)
Marketedpenciclovir
Herpes Labialis (Oral Herpes)
Marketedrepaglinide
Type 2 Diabetes
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
- phase3Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis
- N/AA Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations
- N/AClinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations
- phase1A Relative Bioavailability Study of 100 mg Flavoxate Hydrochloride Tablets Under Fasting Conditions
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that